Intrinsic Value of S&P & Nasdaq Contact Us

Elevance Health Inc. ELV NYSE

NYSE • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
62/100
3/7 Pass
SharesGrow Intrinsic Value
$848.27
+170.7%
Analyst Price Target
$382.64
+22.1%

Stock Statistics — ELV

Elevance Health Inc. (ELV) has a market capitalization of $69.16B and trades at $313.35. The 52-week range is 273.71-458.75.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 12.4, Earnings Per Share (EPS) of $25.18, annual revenue of $199.13B.

The stock has a beta of 0.50, a last dividend of $6.8500, operates in the Healthcare sector.

Trading Data
Current Price$313.35
52-Week Range273.71-458.75
Volume1.35M
Avg Volume (30D)1.98M
Market Cap$69.16B
Beta (1Y)0.50
Last Dividend$6.8500
Company
IPO Date2001-10-30
Employees104,200
CEOGail Koziara Boudreaux
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS0367521038
CUSIP036752103
Income (Latest Year)
Revenue$199.13B
Gross Profit$50.9B
EBITDA$9.66B
Operating Income$8.11B
Net Income$5.66B
EPS$25.18
EPS Diluted$25.12
Shares Outstanding$221.8M
Balance Sheet (Latest Year)
Total Assets$121.49B
Current Assets$24.73B
Cash & ST Investments$9.49B
Total Liabilities$77.47B
Total Debt$33.24B
Net Debt$23.74B
Total Equity$44.03B
Debt / Equity0.75
Valuation Ratios
P/E Ratio12.4
P/S Ratio0.35
P/B Ratio1.57
EV/EBITDA (approx)7.2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message